Companies - Galapagos


Price: Price

-

Change

-

Change %

-

Open

-

High

-

Low

-

Volume

-
Profile: Profile

Galapagos is a service company for the pharmaceutical companies. It is specialized in the discovery of proteins that cause disease. The company is also active in the development of new molecules. While it focuses on arthritis, osteoporosis and osteoarthritis.

Site

http://www.glpg.com

Industry

Biotechnology

Description

Companies in the biotechnology industry are performing research and development activities for the purpose of discovering new drugs and diagnostics. The turnover of these companies comes from sales of these products or the sale of licenses of drugs and diagnostic to other companies.
Key figures (2020): The ratios below are calculated using the last known share price and the last known company financials.

Ratios per share

Price to Earnings

-17,148

Price to Earnings (3 years)

-84,999

Price to Earnings (5 years)

-106,219

Price to earnings growth

-5,547

Price/cashflow

-17,148

Price/net cashflow

-

Price/book value

-

Price to sales

9,877

Ratios for dividend

Dividend yield

-

Pay out

-

Valuation ratios

Market value/PE

-

Market value/turnover

9,877

Enterprise value/turnover

0,950

Return ratios

Return on private equity

-

Return on total equity

-5,34%

Profit margin

-57,60%

Risk ratios

Solvability

-

Solvability

-

Current ratio

8,452

Debt to Equity

-

Value invest ratios

Grahams Number

-

Grahams Value

-

Grahams Product

-

Grahams Product (3 years)

-
2020: Profit and loss

Net profit (x 1 mln)

€ -305,44

Turnover (x 1 mln)

€ 530,26

Cashflow(x 1 mln)

€ -305,44

Net cashflow(x 1 mln)

-

Balance

Private equity (x 1 mln)

-

Foreign equity (x 1 mln)

-

Current assets (x 1 mln)

€ 5.369,35

Current liabilities (x 1 mln)

€ 635,27

Working capital (x 1 mln)

€ 4.734,08

Balance total (x 1 mln)

€ 5.717,73

Share

Outstanding shares (x 1 mln)

65,080

Price year-end

€ 80,48

Dividend per share

-

Earnings per share

€ -4,69

Cashflow per share

€ -4,69

Net cashflow per share

-

Book value per share

-

Stockmarket value (x 1 mln)

€ 5.237,64
History: Year

2020

2019

2018

2017

2016

Net profit (x 1 mln)

€ -305,44

€ 149,84

€ -29,26

€ -115,70

€ 54,01

Turnover (x 1 mln)

€ 530,26

€ 895,88

€ 317,85

€ 155,92

€ 151,61

Price year-end

€ 80,48

€ 186,50

€ 80,56

€ 78,98

€ 60,94

Year high

€ 252,90

€ 198,40

€ 105,35

€ 89,75

€ 66,19

Year low

€ 74,98

€ 77,16

€ 70,64

€ 59,13

€ 32,50

Outstanding shares (x 1 mln)

65,080

64,670

54,470

50,940

45,696

Price to Earnings

-17,148

80,492

-149,969

-34,773

51,559

Earnings per share

€ -4,69

€ 2,32

€ -0,54

€ -2,27

€ 1,18

Dividends

-

-

-

-

-

Dividend yield

-

-

-

-

-

Pay out

-

-

-

-

-

Private equity (x 1 mln)

-

-

-

-

€ 758,70

PE per share

-

-

-

-

€ 16,60

Balance total (x 1 mln)

€ 5.717,73

€ 6.068,61

€ 1.439,50

€ 1.286,27

€ 1.083,34

Stockmarket value (x 1 mln)

€ 5.237,64

€ 12.060,96

€ 4.388,10

€ 4.023,24

€ 2.784,71
Company analysis: Analysis of profit indicators

Average profit per share (9 years)

€ -0,85

Standard deviation average profit

€ 2,12 (-249,44%)

Average annual growth rate

17,89%

Compound annual growth percentage

-6,65%

Galapagos

Shares

Compare

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.

Ok Decline